Day ML - Search Results

1

The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation.

Najy AJ, Day KC, Day ML. Najy AJ, et al. Among authors: day ml, day kc. J Biol Chem. 2008 Jun 27;283(26):18393-401. doi: 10.1074/jbc.M801329200. Epub 2008 Apr 22. J Biol Chem. 2008. PMID: 18434311 Free PMC article.

2

Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway.

Day ML, Foster RG, Day KC, Zhao X, Humphrey P, Swanson P, Postigo AA, Zhang SH, Dean DC. Day ML, et al. Among authors: day kc. J Biol Chem. 1997 Mar 28;272(13):8125-8. doi: 10.1074/jbc.272.13.8125. J Biol Chem. 1997. PMID: 9079623

3

Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells.

Zhao X, Gschwend JE, Powell CT, Foster RG, Day KC, Day ML. Zhao X, et al. Among authors: day ml, day kc. J Biol Chem. 1997 Sep 5;272(36):22751-7. doi: 10.1074/jbc.272.36.22751. J Biol Chem. 1997. PMID: 9278434

4

E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway.

Day ML, Zhao X, Vallorosi CJ, Putzi M, Powell CT, Lin C, Day KC. Day ML, et al. Among authors: day kc. J Biol Chem. 1999 Apr 2;274(14):9656-64. doi: 10.1074/jbc.274.14.9656. J Biol Chem. 1999. PMID: 10092652

5

Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line.

Panvichian R, Orth K, Pilat MJ, Day ML, Day KC, Yee C, Kamradt JM, Pienta KJ. Panvichian R, et al. Among authors: day ml, day kc. Urology. 1999 Oct;54(4):746-52. doi: 10.1016/s0090-4295(99)00224-1. Urology. 1999. PMID: 10510942

6

Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution.

Vallorosi CJ, Day KC, Zhao X, Rashid MG, Rubin MA, Johnson KR, Wheelock MJ, Day ML. Vallorosi CJ, et al. Among authors: day ml, day kc. J Biol Chem. 2000 Feb 4;275(5):3328-34. doi: 10.1074/jbc.275.5.3328. J Biol Chem. 2000. PMID: 10652321

7

Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.

Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA, Day ML. Rashid MG, et al. Among authors: day ml. Cancer Res. 2001 Jan 15;61(2):489-92. Cancer Res. 2001. PMID: 11212238

8

Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors.

Chaib H, Rubin MA, Mucci NR, Li L, Taylor JMG, Day ML, Rhim JS, Macoska JA. Chaib H, et al. Among authors: day ml. Cancer Res. 2001 Mar 15;61(6):2390-4. Cancer Res. 2001. PMID: 11289102

9

RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells.

Zhao X, Day ML. Zhao X, et al. Among authors: day ml. Urology. 2001 May;57(5):860-5. doi: 10.1016/s0090-4295(01)00946-3. Urology. 2001. PMID: 11337282

10

E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.

Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML. Rubin MA, et al. Among authors: day ml. Hum Pathol. 2001 Jul;32(7):690-7. doi: 10.1053/hupa.2001.25902. Hum Pathol. 2001. PMID: 11486167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results